Kronos Bio, Inc. (KRON)
NASDAQ: KRON · Real-Time Price · USD
0.8720
+0.0021 (0.24%)
At close: Jun 6, 2025, 4:00 PM
0.8890
+0.0170 (1.95%)
After-hours: Jun 6, 2025, 7:42 PM EDT

Kronos Bio Statistics

Total Valuation

Kronos Bio has a market cap or net worth of $53.17 million. The enterprise value is -$22.48 million.

Market Cap 53.17M
Enterprise Value -22.48M

Important Dates

The next estimated earnings date is Tuesday, June 17, 2025, after market close.

Earnings Date Jun 17, 2025
Ex-Dividend Date n/a

Share Statistics

Kronos Bio has 60.97 million shares outstanding. The number of shares has increased by 3.52% in one year.

Current Share Class 60.97M
Shares Outstanding 60.97M
Shares Change (YoY) +3.52%
Shares Change (QoQ) +0.77%
Owned by Insiders (%) 27.83%
Owned by Institutions (%) 31.70%
Float 44.00M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 5.73
Forward PS n/a
PB Ratio 0.67
P/TBV Ratio 0.67
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.93, with a Debt / Equity ratio of 0.30.

Current Ratio 12.93
Quick Ratio 12.66
Debt / Equity 0.30
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -59.49% and return on invested capital (ROIC) is -23.57%.

Return on Equity (ROE) -59.49%
Return on Assets (ROA) -21.73%
Return on Invested Capital (ROIC) -23.57%
Return on Capital Employed (ROCE) -50.47%
Revenue Per Employee $919,200
Profits Per Employee -$6.45M
Employee Count 10
Asset Turnover 0.06
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +16.16% in the last 52 weeks. The beta is 1.64, so Kronos Bio's price volatility has been higher than the market average.

Beta (5Y) 1.64
52-Week Price Change +16.16%
50-Day Moving Average 0.77
200-Day Moving Average 0.91
Relative Strength Index (RSI) 71.44
Average Volume (20 Days) 1,410,788

Short Selling Information

The latest short interest is 547,885, so 0.90% of the outstanding shares have been sold short.

Short Interest 547,885
Short Previous Month 671,404
Short % of Shares Out 0.90%
Short % of Float 1.25%
Short Ratio (days to cover) 0.58

Income Statement

In the last 12 months, Kronos Bio had revenue of $9.19 million and -$64.49 million in losses. Loss per share was -$1.07.

Revenue 9.19M
Gross Profit 9.19M
Operating Income -50.60M
Pretax Income -102.85M
Net Income -64.49M
EBITDA -49.14M
EBIT -50.60M
Loss Per Share -$1.07
Full Income Statement

Balance Sheet

The company has $99.73 million in cash and $24.09 million in debt, giving a net cash position of $75.65 million or $1.24 per share.

Cash & Cash Equivalents 99.73M
Total Debt 24.09M
Net Cash 75.65M
Net Cash Per Share $1.24
Equity (Book Value) 79.81M
Book Value Per Share 1.31
Working Capital 93.99M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$54.38 million and capital expenditures $3,000, giving a free cash flow of -$54.38 million.

Operating Cash Flow -54.38M
Capital Expenditures 3,000
Free Cash Flow -54.38M
FCF Per Share -$0.89
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -550.46%
Pretax Margin -701.53%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Kronos Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.52%
Shareholder Yield -3.52%
Earnings Yield -121.29%
FCF Yield -102.28%

Analyst Forecast

The average price target for Kronos Bio is $1.63, which is 86.93% higher than the current price. The consensus rating is "Buy".

Price Target $1.63
Price Target Difference 86.93%
Analyst Consensus Buy
Analyst Count 3
Revenue Growth Forecast (5Y) 48.62%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Kronos Bio has an Altman Z-Score of -6.94 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -6.94
Piotroski F-Score 3